Ieq Capital LLC Takes Position in Nutrien Ltd. $NTR

Ieq Capital LLC bought a new stake in Nutrien Ltd. (NYSE:NTR) in the second quarter, Holdings Channel.com reports. The institutional investor bought 10,173 shares of the company’s stock, valued at approximately $640,000.

A number of other institutional investors have also added to or reduced their stakes in NTR. Montag A & Associates Inc. increased its holdings in shares of Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of Nutrien by 1,014.0% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company’s stock worth $30,000 after purchasing an additional 436 shares during the period. Global Retirement Partners LLC bought a new position in shares of Nutrien in the 2nd quarter worth $30,000. Evolution Wealth Management Inc. acquired a new stake in Nutrien in the 1st quarter valued at $32,000. Finally, Allied Private Wealth LLC acquired a new stake in Nutrien in the 2nd quarter valued at $33,000. 63.10% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on NTR. Berenberg Bank set a $65.00 price target on shares of Nutrien and gave the company a “hold” rating in a research note on Wednesday, June 10th. Barclays dropped their price objective on shares of Nutrien from $81.00 to $78.00 and set an “overweight” rating on the stock in a research note on Monday, August 10th. TD Securities reissued a “buy” rating on shares of Nutrien in a research report on Wednesday, May 6th. Weiss Ratings upgraded shares of Nutrien from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 6th. Finally, UBS Group dropped their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research report on Monday, May 11th. Seventeen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $81.58.

Nutrien Stock Performance

Shares of NTR stock opened at $73.64 on Friday. The firm has a 50-day moving average of $67.33 and a 200-day moving average of $70.56. The company has a market cap of $35.23 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.78 and a beta of 0.61. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86. Nutrien Ltd. has a one year low of $53.03 and a one year high of $85.36.

Nutrien (NYSE:NTR) last released its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The firm had revenue of $10.81 billion for the quarter, compared to analysts’ expectations of $10.44 billion. During the same quarter last year, the firm posted $2.65 earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities research analysts forecast that Nutrien Ltd. will post 4.71 EPS for the current fiscal year.

Nutrien Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend is Tuesday, September 29th. Nutrien’s dividend payout ratio (DPR) is presently 44.53%.

Trending Headlines about Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.